|
[1]
|
Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Inoue, M. (2021) Public Health Interventions for Gastric Cancer Control. Gastrointestinal Endoscopy Clinics of North America, 31, 441-449. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Huang, R.J. and Hwang, J.H. (2021) Improving the Early Diag-nosis of Gastric Cancer. Gastrointestinal Endoscopy Clinics of North America, 31, 503-517. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
贠建蔚, 齐国卿, 张德奎. 幽门螺杆菌分型的研究现状[J]. 中华传染病杂志, 2021, 39(4): 243-247.
|
|
[5]
|
Shafaie, E., et al. (2018) Multiplex Serology of Helicobacter pylori Anti-gens in Detection of Current Infection and Atrophic Gastritis—A Simple and Cost-Efficient Method. Microbial Path-ogenesis, 119, 137-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Alipour, M. (2021) Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. Journal of Gastrointestinal Cancer, 52, 23-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Cheok, Y.Y., et al. (2021) An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms, 9, 2502. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ansari, S. and Yamaoka, Y. (2017) Survival of Helicobacter pylori in Gastric Acidic Territory. Helicobacter, 22, e12386. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Padda, J., et al. (2021) Association between Helicobacter pylori and Gastric Carcinoma. Cureus, 13, e15165. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Camilo, V., Sugiyama, T. and Touati, E. (2017) Pathogenesis of Helico-bacter pylori Infection. Helicobacter, 22, e12405. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Liu, W., et al. (2021) A Retrospective Study Assessing the Acceleration Effect of Type I Helicobacter pylori Infection on the Progress of Atrophic Gastritis. Scientific Reports, 11, Article No. 4143. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sharndama, H.C. and Mba, I.E. (2022) Helicobacter pylori: An Up-to-Date Overview on the Virulence and Pathogenesis Mechanisms. Brazilian Journal of Microbiology, 53, 33-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Bakhti, S.Z., et al. (2019) Inverse Association of Helicobacter pylori cagPAI Genotypes with Risk of Cardia and Non-Cardia Gastric Adenocarcinoma. Cancer Medicine, 8, 4928-4937. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tegtmeyer, N., et al. (2017) Subversion of Host Kinases: A Key Network in Cellular Signaling Hijacked by Helicobacter pylori CagA. Molecular Microbiology, 105, 358-372. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Takahashi-Kanemitsu, A., Knight, C.T. and Hatakeyama, M. (2020) Molecular Anatomy and Pathogenic Actions of Helicobacter pylori CagA That Underpin Gastric Carcinogenesis. Cel-lular and Molecular Immunology, 17, 50-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ansari, S. and Yamaoka, Y. (2020) Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity. International Journal of Molecular Sciences, 21, 7430. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
万秀坤, 刘纯杰. 幽门螺杆菌CagA蛋白及其致病机制的研究进展[J]. 微生物学报, 2016, 56(12): 1821-1830.
|
|
[18]
|
Yuan, X.Y., et al. (2017) Helicobacter pylori with East Asian-Type cagPAI Genes Is More Virulent than Strains with Western-Type in Some cagPAI Genes. Brazilian Journal of Microbi-ology, 48, 218-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Hatakeyama, M. (2017) Structure and Function of Helicobacter pylori CagA, the First-Identified Bacterial Protein Involved in Human Cancer. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 93, 196-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Sulzmaier, F.J., Jean, C. and Schlaepfer, D.D. (2014) FAK in Cancer: Mechanistic Findings and Clinical Applications. Nature Reviews Cancer, 14, 598-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Tsutsumi, R., et al. (2006) Focal Adhesion Kinase Is a Substrate and Down-stream Effector of SHP-2 Complexed with Helicobacter pylori CagA. Molecular and Cellular Biology, 26, 261-276. [Google Scholar] [CrossRef]
|
|
[22]
|
Saadat, I., et al. (2007) Helicobacter pylori CagA Targets PAR1/MARK Kinase to Disrupt Epithelial Cell Polarity. Nature, 447, 330-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Rasi-Bonab, F., et al. (2021) Antibiotic Resistance Pattern and Frequency of cagA and vacA Genes in Helicobacter pylori Strains Isolated from Patients in Tabriz City, Iran. BMC Research Notes, 14, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chauhan, N., et al. (2019) Helicobacter pylori VacA, a Distinct Toxin Exerts Diverse Functionalities in Numerous Cells: An Overview. Helicobacter, 24, e12544. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
McClain, M.S., Beckett, A.C. and Cover, T.L. (2017) Helicobacter pylori Vacuolating Toxin and Gastric Cancer. Toxins (Basel), 9, 316. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kim, J. and Wang, T.C. (2021) Helicobacter pylori and Gastric Cancer. Gastrointestinal Endoscopy Clinics of North America, 31, 451-465. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Li, H., et al. (2019) How Does Helicobacter pylori Cause Gastric Cancer through Connexins: An Opinion Review. World Journal of Gastroenterology, 25, 5220-5232. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sukri, A., et al. (2020) Epidemiology and Role of Helicobacter pylori Virulence Factors in Gastric Cancer Carcinogenesis. APMIS, 128, 150-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Abdullah, M., et al. (2019) VacA Promotes CagA Accumulation in Gastric Epithelial Cells during Helicobacter pylori Infection. Scientific Reports, 9, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tarsia, C., et al. (2018) Targeting Helicobacter pylori Urease Activity and Maturation: In-Cell High-Throughput Approach for Drug Discovery. Biochimica et Biophysica Acta (BBA)—General Subjects, 1862, 2245-2253. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ha, N.-C., et al. (2001) Supramolecular Assembly and Acid Resistance of Helicobacter pylori Urease. Nature Structural Biology, 8, 505-509. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Olivera-Severo, D., et al. (2017) A New Role for Helicobacter pylori Urease: Contributions to Angiogenesis. Frontiers in Microbiology, 8, Article No. 1883. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Debowski, A.W., et al. (2017) Helicobacter pylori Gene Silencing in Vivo Demonstrates Urease Is Essential for Chronic Infection. PLOS Pathogens, 13, e1006464. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Baj, J., et al. (2020) Helicobacter pylori Virulence Fac-tors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells, 10, 27. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Foegeding, N.J., et al. (2019) Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability. Infection and Immunity, 87, e00783-18. [Google Scholar] [CrossRef]
|
|
[36]
|
Schmalstig, A.A., et al. (2018) Noncatalytic Antioxidant Role for Helicobacter pylori Urease. Journal of Bacteriology, 200, e00124-18. [Google Scholar] [CrossRef]
|
|
[37]
|
Lee, J.H., et al. (2015) Morphological Changes in Human Gastric Epi-thelial Cells Induced by Nuclear Targeting of Helicobacter pylori Urease Subunit A. Journal of Microbiology, 53, 406-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Valenzuela-Valderrama, M., et al. (2019) The Helicobacter pylori Urease Virulence Factor Is Required for the Induction of Hypoxia-Induced Factor-1alpha in Gastric Cells. Cancers (Basel), 11, 799. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Graham, D.Y. and Miftahussurur, M. (2018) Helicobacter pylori Urease for Diagnosis of Helicobacter pylori Infection: A Mini Review. Journal of Advanced Research, 13, 51-57. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Mohammadian, T. and Ganji, L. (2019) The Diagnostic Tests for Detection of Helicobacter pylori Infection. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 38, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
O’Connor, A. (2021) The Urea Breath Test for the Noninvasive De-tection of Helicobacter pylori. Methods in Molecular Biology, 2283, 15-20. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Zhou, J.T., et al. (2017) Inhibition of Helicobacter pylori and Its Associated Urease by Palmatine: Investigation on the Potential Mechanism. PLOS ONE, 12, e0168944. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Li, C., et al. (2018) Coptisine-Induced Inhibition of Helico-bacter pylori: Elucidation of Specific Mechanisms by Probing Urease Active Site and Its Maturation Process. Journal of Enzyme Inhibition and Medicinal Chemistry, 33, 1362-1375. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Mamidala, R., Bhimathati, S.R.S. and Vema, A. (2021) Discovery of Novel Dihydropyrimidine and Hydroxamic Acid Hybrids as Potent Helicobacter pylori Urease Inhibitors. Bioorganic Chemistry, 114, Article ID: 105010. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Dos Santos Viana, I., et al. (2021) Vaccine Development against Helicobacter pylori: From Ideal Antigens to the Current Landscape. Expert Review of Vaccines, 20, 989-999. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Ichihara, A., et al. (2021) Serodiagnosis and Bacterial Ge-nome of Helicobacter pylori Infection. Toxins (Basel), 13, 467. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Jeske, R., et al. (2020) Development of Helicobacter pylori Whole-Proteome Arrays and Identification of Serologic Biomarkers for Noncardia Gastric Cancer in the MCC-Spain Study. Cancer Epidemiology, Biomarkers & Prevention, 29, 2235-2242. [Google Scholar] [CrossRef]
|
|
[48]
|
Yuan, L., et al. (2020) Type I and Type II Helicobacter pylori Infection Status and Their Impact on Gastrin and Pepsinogen Level in a Gastric Cancer Prevalent Area. World Journal of Gastroenterology, 26, 3673-3685. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
El Hafa, F., et al. (2022) Association between Helicobacter pylori Antibodies Determined by Multiplex Serology and Gastric Cancer Risk: A Meta-Analysis. Helicobacter, 27, e12881. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Liu, W., Sun, Y. and Yuan, Y. (2020) Analysis of Serum Gastrin-17 and Helicobacter pylori Antibody in Healthy Chinese Population. Journal of Clinical Laboratory Analysis, 34, e23518. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Lin, Z., et al. (2021) Application of Serum Pepsinogen and Carbohydrate Antigen 72-4 (CA72-4) Combined with Gastrin-17 (G-17) Detection in the Screening, Diagnosis, and Evaluation of Early Gastric Cancer. Journal of Gastrointestinal Oncology, 12, 1042-1048. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Han, X.L., et al. (2022) Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Laboratory Medicine, 53, 71-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Kishk, R.M., et al. (2021) Genotyping of Helicobacter pylori Viru-lence Genes cagA and vacA: Regional and National Study. International Journal of Microbiology, 2021, Article ID: 5540560. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
国家消化系疾病临床医学研究中心, 国家消化道早癌防治中心联盟(GECA), 中华医学会消化病学分会幽门螺杆菌学组, 等. 中国幽门螺杆菌根除与胃癌防控的专家共识意见(2019年, 上海) [J]. 中华消化杂志, 2019, 39(5): 310-316.
|
|
[55]
|
Li, Y., et al. (2021) Genotyping Helicobacter pylori Antibiotic Resistance and Virulence-Associated Genes in Patients with Gastric Cancer in Wenzhou, China. Arab Journal of Gastroenterology, 22, 267-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Suzuki, S., et al. (2022) The Ideal Helicobacter pylori Treatment for the Present and the Future. Digestion, 103, 62-68. [Google Scholar] [CrossRef] [PubMed]
|